SBI Securities’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16
Closed -$3 4092
2025
Q3
$3 Buy
+16
New +$19 ﹤0.01% 4131

SBI Securities's EPIX Position: Q4 2025 in Review

SBI Securities sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 16 shares — an estimated $3 sold.

SBI Securities first reported a position in EPIX in Q3 2025 and held it in 1 quarter. The position peaked at $3 in Q3 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

  • SBI Securities reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 16 ESSA Pharma shares in Q4 2025, an estimated $3.
  • SBI Securities first reported a position in ESSA Pharma in Q3 2025 and held it in 1 quarter.
  • SBI Securities's ESSA Pharma position peaked at $3 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.